What Happened?
South San Francisco, CA-based Genentech Appointed Andrew Case as Head of Supply Chain - Cell and Gene Therapies at Genentech/Roche
About the Company
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for over 35 years. At Genentech, we use human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions. Today, we are among the world`s leading biotech companies, with multiple products on the market and a promising development pipeline.
About the Person
Andrew Case is Head of Supply Chain - Cell and Gene Therapies at Genentech/Roche at Genentech. Previously, Andrew held various senior HR leadership roles in the industry.
Info Source
News
Short Profile